UNITY Biotechnology Reports Granting of New Employment Inducement Award
UNITY Biotechnology Reports Granting of New Employment Inducement Award
SOUTH SAN FRANCISCO, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. ("UNITY") [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that the Compensation Committee of the Board of Directors (the "Board") granted a stock-based award to a new employee, the company's chief strategy officer, effective as of July 22, 2024, covering an aggregate of 115,000 shares of UNITY common stock, including options to purchase an aggregate of 100,000 shares of UNITY common stock and 15,000 Restricted Stock Units of UNITY common stock. The stock-based awards were granted pursuant to the UNITY 2020 Employment Inducement Incentive Plan, as amended, which was approved by the Board in March 2020 to provide for grants to newly hired employees as a material inducement for them to commence employment with UNITY in accordance with Nasdaq Stock Market Rule 5635(c)(4).
加利福尼亚州南旧金山市,2024年7月24日(环球新闻社) - UNITY生物技术公司(“UNITY”)[纳斯达克:UBX],一家生物技术公司,正在开发药物来减缓、停止或逆转衰老疾病,今天宣布董事会的薪酬委员会向新员工授予基于股票的奖励,即该公司的首席策略官,自2024年7月22日起生效,涵盖115,000股UNITY普通股的总计,其中包括购买100,000股UNITY普通股的期权,以及15,000 UNITY普通股的受限股票单位。这些基于股票的奖励是根据UNITY 2020年就业激励计划(经修改),依照纳斯达克证券交易所规则5635(c)(4)批准,该计划于2020年3月获得董事会批准,为新雇用员工提供资助,以作为他们与UNITY开始就业的重要诱因。
About UNITY
UNITY is developing a new class of therapeutics to slow, halt, or reverse diseases of aging. UNITY's current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. More information is available at or follow us on X and LinkedIn.
关于UNITY
UNITY正在开发一类新的治疗药物来减缓、停止或逆转衰老疾病。UNITY目前的重点是创建药品,以选择性地消除或调节衰老细胞,从而在与年龄相关的眼科和神经疾病中提供转化性的好处。更多信息可查询 或关注我们的 X 和领英页面。
Media Contact
Inizio Evoke Comms
Katherine Smith
Katherine.Smith@inizioevoke.com
媒体联系人
Inizio Evoke Comms
凯瑟琳·史密斯
Katherine.Smith@inizioevoke.com
Investor Contact
LifeSci Advisors, LLC
Joyce Allaire
jallaire@lifesciadvisors.com
投资者联系方式
LifeSci Advisors,LLC
乔伊斯·阿莱尔
jallaire@lifesciadvisors.com